Technetium (99mTc) medronic acid
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
Methylenebis(phosphonic acid) technetium (99mTc) | |
| Clinical data | |
| Routes of administration | intravenous |
| Identifiers | |
| ATC code | V09BA02 |
| PubChem | CID 157443 |
| Chemical data | |
| Formula | CH6O6P2 • x99mTc |
| Molar mass | unknown |
| (verify) | |
Technetium (99mTc) medronic acid is a pharmaceutical product used in nuclear medicine to localize bone metastases[1] as well as other diseases that can alter the natural turn-over in the bone.[2]
Chemistry
The drug is a complex of medronic acid, the simplest bisphosphonate, with technetium-99m (99mTc), a radionuclide that emits gamma rays. The exact structure of the complex is not known.[2][3]
References
This article is issued from Wikipedia - version of the Friday, November 07, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
